Deep Breeze Breakthrough Lets Patients Breathe Better

Around the globe, some 200 million people suffer from chronic obstructive pulmonary disease (COPD), a progressive lung condition usually triggered by long-term smoking. As the disease worsens, patients typically face hospitalization several times a year – at a cost of thousands of dollars per day.

An Israeli company’s innovative medical device could radically change that scenario. Once approved by the US Food and Drug Administration (FDA), the trademarked Breeze@home, will allow COPD and other chronic lung disease patients to stay out of the hospital while receiving continuous remote monitoring by their healthcare provider from home.

“This will not only make life more bearable for them, but will also save the healthcare system a lot of money,” points out Dr. Michael Nagler, CEO of Deep Breeze Continue reading

Researchers Devise Easy, Accurate Way to Predict Food Allergies

An on-line calculator that predicts, within seconds, the presence of the three major food allergies in children has been developed by researchers at University College Cork. They have devised a new ‘Cork-Southampton calculator’ that gives 96% accuracy compared to current methods that are 61% 81% accurate. The research will be published online tomorrow in the leading international allergy journal, Journal of Allergy & Clinical Immunology.

Food allergies have increased over the past decade as has the number of patients and parents seeking diagnosis. Double-blind, placebo-controlled food challenges are the gold standard for diagnosing food allergy, but they are time-consuming,  Continue reading